Abstract
This chapter focuses on patients with a preexisting inflammatory arthritis subsequently treated by immune checkpoint inhibitor (ICI) therapy for malignancy. We summarize the available epidemiologic and pathologic studies involving this subgroup of patients. An illustrative case of a patient with preexisting rheumatoid arthritis exposed to ICI for melanoma and followed longitudinally is presented in detail to highlight the clinical course and management challenges faced when caring for these patients.
Original language | English (US) |
---|---|
Title of host publication | Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy |
Subtitle of host publication | A Handbook for Diagnosis and Management |
Publisher | Springer International Publishing |
Pages | 273-291 |
Number of pages | 19 |
ISBN (Electronic) | 9783030568245 |
ISBN (Print) | 9783030568238 |
DOIs | |
State | Published - Feb 16 2021 |
Keywords
- Immune checkpoint inhibitors
- Immune-related adverse events
- Inflammatory arthritis
- Preexisting rheumatic diseases
ASJC Scopus subject areas
- Medicine(all)
- Immunology and Microbiology(all)